Med Sci Monit 2011;17:BR35-41.ArticlePubMedPMC 104
This was based on the evidence collected from seven clinical trials conducted in 33 countries with 4,087 patients with type 2 diabetes (US FDA 2017
11 MorieriMLConsoliASestiGPurrelloFAvogaroAFadiniGP
As of March 2025, 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs
For weekly GLP-1 medications, patients might use the right abdomen one week, left abdomen the next, then alternate thighs, creating a four-week rotation cycle
Further, a clinical trial of over 3,000 people living with type 2 diabetes and chronic kidney disease found that semaglutide led to improvement for kidney, cardiovascular, and survival outcomes including a 24% reduced risk of kidney disease events and18% lower risk of major cardiovascular events compared to placebo